Labconco Announces Jeff Stanton as New Executive Vice President

GE HEALTHCARE LIFE SCIENCES AND GOSILICO AGREE TO CO-MARKET CHROMX MECHANISTIC MODELING SOFTWARE

THE AGREEMENT FACILITATES THE ADOPTION OF CHROMX BY SCIENTISTS AND USERS OF RESINS, COLUMNS, AND CHROMATOGRAPHY SYSTEMS INTO THEIR DOWNSTREAM PROCESS DEVELOPMENT WORKFLOWS FOR THE BENEFIT OF ACCELERATED DEVELOPMENT TIMELINES AND IMPROVED PROCESS ROBUSTNESS. Uppsala, Sweden and Karlsruhe, Germany –  GE Healthcare Life Sciences and GoSilico, a software company, have signed an agreement to co-market [...]

The Julius Wolf Institute at the Charité installs mission-critical MILabs microCT for in-vivo studies of musculoskeletal regeneration

Berlin-Germany and Utrecht, Netherlands The Julius Wolff Institute for Biomechanics and Musculoskeletal Regeneration at the Charité – Universitätsmedizin Berlin has installed a MILabs extra ultra-high resolution microCT (U-CT XUHR) system as an essential research tool to study the interplay between biology and mechanical strain. The unit will be used to to study the effects of [...]

Seven Bridges Announces Transformative Solution for Analyzing Genomic and Phenotypic Data to Accelerate Novel Drug Development

Seven Bridges ARIA™ Will Support Research Projects at the 1M+ Participant Scale BOSTON -- Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced Seven Bridges ARIA™, the first cloud-based solution aimed at improving and accelerating the discovery of meaningful connections between genomics, health data and biological knowledge at the 1M+ participant scale. By connecting genetics and [...]

TwinStrand Biosciences Launches Duplex Sequencing Technology

SEATTLE -- TwinStrand Biosciences™, a next-generation DNA sequencing technology company, today announced the launch of TwinStrand Duplex Sequencing™ Technology kits at the annual Advances in Genome Biology and Technology (AGBT) General Meeting in Marco Island, Florida. At launch, the company will offer their platform technology for two research applications: detection of minimal residual disease in acute [...]

Seven Bridges Announces Transformative Solution for Analyzing Genomic and Phenotypic Data to Accelerate Novel Drug Development

Seven Bridges ARIA™ Will Support Research Projects at the 1M+ Participant Scale BOSTON — Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced Seven Bridges ARIA™, the first cloud-based solution aimed at improving and accelerating the discovery of meaningful connections between genomics, health data and biological knowledge at the 1M+ participant scale. By connecting genetics [...]

Stilla Technologies, Yuzi Holdings and TusPark donate digital PCR Naica™ Systems to help fight coronavirus outbreak in China

A Franco-Chinese collaboration to better detect the virus and monitor its mutations Paris - Stilla Technologies, a leading provider of pioneering digital PCR (dPCR) solutions for high-precision genetic analyses, just announced it will be joining an initiative led by Yuzi Holdings and TusPark Science & Technology Service Group (TusPark) to donate two Naica Systems to City [...]

Bit Bio Secures Distribution Agreement with Abcam to Democratize Access to Human Cells for Global Life Science Research

CAMBRIDGE, England -- Bit Bio announces agreement with Abcam, a global innovator in life science reagents and tools, to make Bit Bio's iPSC derived functional human cells widely available to the global life science community. Over the course of the next two years this new partnership will provide an increasing range of highly defined, scalable [...]

Certara’s Simcyp Division Acquires Modeling and Simulation Platform for Neurodegenerative Diseases from In Silico Biosciences, Inc.

Acquisition will spur the development of new drugs to treat complex neurodegenerative conditions, including Alzheimer’s and Parkinson’s disease PRINCETON, NJ  – Certara®, the global model-informed drug development and decision support leader, today reported that it has acquired a range of modeling and simulation technology assets from In Silico Biosciences, Inc. The assets include a platform [...]

Scipio bioscience raises €6.0 M Series A financing

To develop and launch a kit dedicated to sample preparation for single-cell RNAsequencing Paris - Scipio bioscience, a Paris-based biotechnology company, developing a new generation of single-cell sequencing solutions, announces today that it has secured a €6.0 M Series A financing from an international syndicate led by M Ventures (Amsterdam, The Netherlands), the corporate venture [...]

Access IBO on Knowledge Center